LRRK2 and Parkinson disease: Moreover, emerging evidence suggests increased LRRK2 activity in the post-mortem brains from people with PD (Di Maio et al., 2018), as well as in peripheral tissues (Fraser et al., 2016; Atashrazm et al., 2019).